New research shows promise using immunotherapy in the fight against lung cancer. Dr. Laura Chow, a clinical investigator and expert at The Fred Hutchinson Cancer Research Center, discusses the PD-1 targeted immune therapy trial and results for patients. Hear from patient Eva Borsi about her experience with late stage non-small cell lung cancer and this trial.
|
Laura Chow, M.D.
Assistant Member, Clinical Research, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance
Dr. Laura Chow is an Assistant Professor, Medical Oncology, University of Washington School of Medicine and Assistant Member, Clinical Research, at the Fred Hutchinson Cancer Research Center. She has expertise in lung cancers, head and neck cancers, esophageal cancers and solid tumor Phase I/early phase clinical trials. Dr. Chow has been a principal investigator and co-investigator in a number of...
more >
|
|
|
|
|
Eva Borsi,
lung cancer patient, Seattle Cancer Care Alliance
Eva Borsi, an avid cyclist and 48-year-old mother of three, is seeing important progress as a participant with immunotherapy treatment in a clinical trial for non-small cell lung cancer. She works in the University of Washington's Dental School and is a committed athlete. She was prompted to visit her primary care provider when this healthy woman first experienced shortness of breath.
more >
|
|
|

